Selinexor Combined With BEAM for ASCT in R/R DLBCL With MYC Positive

NCT06652139 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma

Interventions

DRUG: selinexor combined with BEAM regimen
DRUG: BEAM regimen

Sponsor

Ruijin Hospital